Semnur Pharmaceuticals Statistics
Total Valuation
SMNR has a market cap or net worth of 4.59 billion. The enterprise value is 4.60 billion.
| Market Cap | 4.59B |
| Enterprise Value | 4.60B |
Important Dates
The next estimated earnings date is Friday, December 26, 2025.
| Earnings Date | Dec 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SMNR has 229.74 million shares outstanding. The number of shares has decreased by -15.57% in one year.
| Current Share Class | 229.74M |
| Shares Outstanding | 229.74M |
| Shares Change (YoY) | -15.57% |
| Shares Change (QoQ) | +26.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 28.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -314.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1,674.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -51.68M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.26% in the last 52 weeks. The beta is 0.29, so SMNR's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +51.26% |
| 50-Day Moving Average | 12.47 |
| 200-Day Moving Average | 9.22 |
| Relative Strength Index (RSI) | 63.87 |
| Average Volume (20 Days) | 514 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -155.03M |
| Pretax Income | -155.03M |
| Net Income | -155.03M |
| EBITDA | n/a |
| EBIT | -155.03M |
| Earnings Per Share (EPS) | -0.97 |
Balance Sheet
The company has 85,000 in cash and 9.81 million in debt, giving a net cash position of -9.73 million or -0.04 per share.
| Cash & Cash Equivalents | 85,000 |
| Total Debt | 9.81M |
| Net Cash | -9.73M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -14.59M |
| Book Value Per Share | -0.06 |
| Working Capital | -9.95M |
Cash Flow
| Operating Cash Flow | -3.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SMNR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 15.57% |
| Shareholder Yield | 15.57% |
| Earnings Yield | -3.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |